Broncus Medical affiliate acquires Uptake Medical

Uptake Medical said yesterday that its InterVapor device for treating emphysema is back on the market in Europe after its acquisition for an undisclosed amount by an affiliate of Broncus Medical. Broncus set its purchase up under a new entity based in Seattle, Uptake Medical Technology, and plans to add markets in Australia and Asia to its commercial footprint in Europe by the end of the year. The InterVapor device uses heated water vapor to reduce lung volume in emphysema patients. Uptake won an expanded CE Mark in the European Union for InterVapor in August 2015. “2018 promises to be an exciting year for the new Uptake Medical,” founder &president Robert Barry said in prepared remarks. “With the recent outstanding Step-up multi-center randomized controlled trial results and the backing of Broncus, we are posed for success. In addition, we have very exciting bronchoscopic lung cancer ablation clinical studies underway. When you combine San Jose, Calif.-based Broncus Medical’s Archimedes system for accessing and diagnosing lung disease with [bronchial thermal vapor ablation] you start to see our vision of a complete interventional pulmonology company come to life.” “We also have plans to continue our research of BTVA for emphysema patients and expand the scope of patients that qualify. We are also continuing clinical research and development of our adaptation of the technology for the ablation of several other lung diseases,&r...
Source: Mass Device - Category: Medical Devices Authors: Tags: Mergers & Acquisitions Respiratory Wall Street Beat Broncus Medical Uptake Medical Source Type: news

Related Links:

Publication date: 2018 Source:Respiratory Medicine Case Reports, Volume 25 Author(s): Pradnya D. Patil, Samir Sultan, M. Frances Hahn, Sreeja Biswas Roy, Mitchell D. Ross, Hesham Abdelrazek, Ross M. Bremner, Nitika Thawani, Rajat Walia, Tanmay S. Panchabhai Patients under consideration for lung transplantation as treatment for end-stage lung diseases such as idiopathic pulmonary fibrosis (IPF) often have risk factors such as a history of smoking or concomitant emphysema, both of which can predispose the patient to lung cancer. In fact, IPF itself increases the risk of lung cancer development by 6.8% to 20%. Solid organ ma...
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
Authors: Digumarthy SR, De Man R, Canellas R, Otrakji A, Wang G, Kalra MK Abstract We hypothesized that severity of coronary artery calcification (CAC), emphysema, muscle mass, and fat attenuation can help predict mortality in patients with lung cancer participating in the National Lung Screening Trial (NLST). Following regulatory approval from the Cancer Data Access System (CDAS), all patients diagnosed with lung cancer at the time of the screening study were identified. These subjects were classified into two groups: survivors and nonsurvivors at the conclusion of the NLST trial. These groups were matched based o...
Source: Journal of Oncology - Category: Cancer & Oncology Tags: J Oncol Source Type: research
This study was the largest, longest study to use a less-invasive or minimally-invasive technique using these one-way valves,” Dr. Criner said. Dr. Criner said that after one year, patients treated with the Zephyr valves were significnatly more likely to show improvements in lung function, measured as forced expiratory volume in one second, or FEV1. “Patients that were treated had about a three times greater likelihood of having significant improvement in FEV1, more than 15% in 45% of the treated group compared to 11% of the control,” Dr. Criner said. Additionally, patients treated with the Zephyr reported...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Respiratory Pulmonx Source Type: news
1351Objectives: Analyze the imaging feature of the nodules and clinical information of the patients, to establish a prediction model assess the probability of malignancy in solitary pulmonary nodules which detected on 18F-FDG PET/CT scanning, and compare our model’s performance with the other three models to validate the accuracy. Materials and Methods: The data of the PET / CT center in our hospital from January 2013 to July 2017 were retrospectively analyzed, 362 patients with SPN were included in the study, and the divided into establishment group (group A) and validation group (group B) randomly. The data in grou...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Lung Cancer Posters Source Type: research
516Objectives: Prior to lung resection, it is of paramount importance to predict the postoperative lung function. The current clinical practice is to use planar (2D) scintigraphy with its obvious limitations. The aim of this single center study is to prospectively assess the feasibility and potential value of quantitative SPECT/CT for 3D lung perfusion imaging with anatomical lungs /lobes delineation. Methods Planar and SPECT/CT lung perfusion scans were acquired (Intevo, Siemens) for each patient after 99mTc-labelled macroaggregated albumin (99mTc-MAA) administration. The percentage of total lung perfusion was assessed fo...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Outcomes/Infectious Disease/Pulmonary II Source Type: research
Abstract As marijuana smoking prevalence increases in the U.S. concern regarding its potential risks to lung health has also risen, given the general similarity in the smoke contents between marijuana and tobacco. Most studies have found a significant association between marijuana smoking and chronic bronchitis symptoms after adjustment for tobacco. While reports are mixed regarding associations between marijuana smoking and lung function, none has shown a relationship to decrements in forced expired volume in 1 sec (FEV1) and few have found a relationship to a decreased ratio of FEV1 to forced vital capacity (FVC...
Source: Chest - Category: Respiratory Medicine Authors: Tags: Chest Source Type: research
Abstract OBJECTIVES: To investigate whether patients with emphysema, as evaluated by quantitative CT image measurement, are at risk of developing radiation pneumonitis (RP) after radiotherapy for non-small cell lung cancer (NSCLC). METHODS: Between March 2011 and June 2015, 68 consecutive patients with stage INSCLC treated with a radiotherapy a dose of 75 Gy given in 30 fractions were enrolled. The median age was 79 years and there were 45 males and 23 females. The numbers of patients with T1 and T2 were 49 and 19, respectively. The severity of emphysema was evaluated by the percentages of the low attenuation...
Source: The British Journal of Radiology - Category: Radiology Authors: Tags: Br J Radiol Source Type: research
Conclusion.A substantial proportion of patients diagnosed with lung cancer show impairments in their capacity to make a medical decision. Assessment of cognitive impairment and frailty may provide appropriate decision‐making frameworks to act in the best interest of patients.Implications for Practice.Decision‐making capacity is the cornerstone of clinical practice. A substantial proportion of patients with cancer show impairments in their capacity to make a medical decision. Assessment of cognitive impairment and frailty may provide appropriate decision‐making frameworks to act in the best interest of patients.
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Lung Cancer, Geriatric Oncology Source Type: research
If you have been diagnosed with mesothelioma, you’re likely seeking information and resources to learn more about the disease. A free one-hour mesothelioma teleconference is a great place to start. CancerCare recently hosted the “Advancements in the Treatment of Mesothelioma” workshop. The session featured five mesothelioma experts, including Dr. Hedy Kindler, director of the mesothelioma program at the University of Chicago Comprehensive Cancer Center. The Mesothelioma Applied Research Foundation co-sponsored the teleconference, which is available online for free. All mesothelioma patients can benefit f...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Circulating tumor DNA (ctDNA) analysis has demonstrated excellent specificity and satisfactory sensitivity to detect somatic mutations across many tumor types and particularly in patients with metastatic disease [1,2]. ctDNA detection rate and level primarily depend on tumor burden, proliferation and tumor type [3]. Its clinical use as a theragnostic biomarker for detectingEGFR mutation has been approved in stage IV non-small-cell lung cancer patients, in whom invasive tumor biopsy may be perilous because of limited accessibility and/or pre-existing organ dysfunction (e.g. emphysema). In that regard, biopsies of hepatocell...
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
More News: Australia Health | Bronchoscopy | Cancer | Cancer & Oncology | China Health | Emphysema | Germany Health | Hong Kong Health | Lung Cancer | Medical Devices | Mergers and Aquisitions | Respiratory Medicine | Study | Venture Capital